NASDAQ:ANNX - Nasdaq - US03589W1027 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 182.91M | 154.07M | 143.72M | 145.60M | 130.71M | |||
Research and Development | 146.66M | 119.45M | 113.76M | 112.50M | 100.07M | |||
Selling, General, and Administrative Expenses | 36.24M | 34.63M | 29.97M | 33.10M | 30.65M | |||
Operating Income | -182.91M | -154.07M | -143.72M | -145.60M | -130.71M | |||
Interest Income/Expense | 15.53M | 15.87M | 9.49M | N/A | 10.00K | |||
Other Income/Expense | N/A | N/A | 0.00 | 3.65M | 390.00K | |||
Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
Income Before Taxes | -167.38M | -138.20M | -134.24M | -141.95M | -130.32M | |||
Income Tax | N/A | N/A | N/A | N/A | N/A | |||
Net Income | -167.38M | -138.20M | -134.24M | -141.95M | -130.32M | |||
EBITDA | -180.76M | -151.92M | -141.57M | -143.49M | -128.57M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.15 | -1.01 | -1.77 | -2.60 | -3.40 | |||
Non GAAP EPS | -1.18 | -1.02 | -1.78 | -2.87 | -3.40 | |||
Statistics |
All data in USD